1. García Moll X, Kaski JC. Cardiopatía isquémica: marcadores de inflamación y riesgo cardiovascular. Rev Esp Cardiol 1999; 52:990-1003.
2. Goldberg RJ, Samad NA, Yarzebski J, Gurwitz J, Bigelow C, Gore JM. Temporal trends in cardiogenic shock complicating acute myocardial infarction. N Engl J Med 1999; 340:1162-8.
3. Katz AM. Heart failure. The hemodynamic defense reaction. Pathophysiology, molecular biology and clinical management. Philadelphia: Lippincott, Williams & Wilking, 2000; pp. 109-52.
4. Yamagishi M, Higashikata T, Ishibashi-Ueda H, Sasaki H, Ogino H, Iihara K, et al. Sustained upregulation of inflammatory chemokine and its receptor in aneurysmal and occlusive atherosclerotic disease: results from tissue analysis with cDNA macroarray and real-time reverse transcriptional polymerase chain reaction methods. Circ J 2005; 69:1490-5.
5. Moreau M, Brocheriou I, Petit L, Ninio E, Chapman MJ, Rouis M. Interleukin-8 mediates downregulation of tissue factor inhibitor of metalloproteinase-1 expression in cholesterol-loaded human macrophages: relevance of stability of atherosclerotic plaque. Circulation 1999; 99:420-6.
6.Entman ML, Smith WC. Postreperfusion inflammation: a model for reaction to injury in cardiovascular disease. Cardiovascular disease. Cardiovasc Res 1994;28:1301-11.
7.Killip T, Kimball JT. Treatment of myocardial infarction in a coronary care unit. A two year experience with 250 patients. Am J Cardiol 1967; 20:457-64.
8. Sanjuán Máñez R, Blasco Cortés M, Muñoz Gil J, Gimeno Cardona C, Savall Calvo F, Ferreres Franco J, et al. Respuesta inflamatoria en el infarto agudo de miocardio. Valores predictivos. Rev Esp Cardiol 1997; 50:561-6. |
Domínguez Rodríguez A, Abreu González P, García González M. Usefulness of neopterin levels and left ventricular function for risk assessment in survivors of acute myocardial infarction. Int J Cardiol 2006; 111(2):318-20.
Domínguez Rodríguez A, García González M, Abreu González P, Ferrer J, Kaski JC. Relation of nocturnal melatonin levels to C-reactive protein concentration in patients with ST-segment elevation myocardial infarction. Am J Cardiol 2006; 97(1):10-2.
Domínguez Rodríguez A, Abreu González P, García González M, Reiter RJ. Prognostic value of nocturnal melatonin levels as a novel marker in patients with ST-segment elevation myocardial infarction. Am J Cardiol 2006; 97(8):1162-4. |
